Briefs: Zydus, Advanced Enzyme Technologies, Link Pharma Chem and ANVISA
ANVISA issues CGMP to Concord Biotech’s Unit I
ANVISA issues CGMP to Concord Biotech’s Unit I
Sharma joined the Morepen Lab in 2004
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty
Acquisition of exclusive commercialization rights for European markets
The Convocation ceremony was organized for students skilled and certified in Ayush
This agreement paves the way for the introduction of YESAFILI into the Canadian market
Subscribe To Our Newsletter & Stay Updated